Delivery Order SPE2DB25D3202-SPE2DB25FSZGR

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,184.33 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 140 mg/mL Repatha SureClick autoinjectors, a specialty medication used to treat cardiovascular conditions. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) covers the delivery of Repatha 140 mg/ml SureClick autoinjector medication. The $2,033.64 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
The Defense Logistics Agency (DLA) awarded a $2,156.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Repatha 140 mg/mL SureClick injections. This contract is a child of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,777.43 firm-fixed-price contract is for the supply of Repatha (evolocumab) 140mg/ml SureClick injectors. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. This delivery order falls under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
This is a $1,016.88 delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Repatha (140 mg/ml) SureClick injectors. The order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs and facilities...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Repatha 140 mg/ml SureClick autoinjectors. The $1,788.82 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to supply a wide range of pharmaceutical products and medical...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $2,033.64 contract is for the provision of Repatha 140 mg/mL SureClick injectable medication. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,417.77, is for the supply of Repatha (140 mg/mL) SureClick autoinjectors. The contract has an ultimate completion date of June 28, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Repatha 140 mg/ml SureClick autoinjectors to support the Medical Supply Chain program of the Defense Logistics Agency (DLA). The contract, awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a firm fixed-price delivery order valued at $5,761.28. The contract has an ultimate completion date of May 18, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.98 firm fixed-price delivery order is for the supply of Repatha (140 mg/mL SureClick) medication, with a performance period through December 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a comprehensive range of pharmaceutical...
  • SPE2DB25D3202
    Indefinite Delivery Contract
  • SPE2DB25D3202-SPE2DB25FSZGR
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $6,078.90 to provide Repatha 140 mg/ml SureClick Autoinjectors. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a comprehensive vehicle for the company to supply a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award exemplifies AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems, where the company leverages its extensive supply chain and distribution capabilities to meet the medical needs of service members and beneficiaries.

Generated 4/11/25, 11:08 AM